Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial DNA (Anaerobic Bacteria) (N/A)
- Target
- N/A
- Molecular classification
- Nucleic Acid, DNA, Chromosome, Plasmid, Extracellular DNA (eDNA)
01
Overview
Bacterial DNA in anaerobic bacteria comprises the genetic material necessary for survival and pathogenicity in oxygen-deprived environments. It typically includes a circular chromosome and often plasmids encoding antibiotic resistance or other adaptive traits. Extracellular DNA (eDNA) contributes significantly to biofilm formation and stability, making it a potential therapeutic target for disrupting anaerobic bacterial communities. Antibiotics act on bacterial DNA to inhibit essential processes. The DNA encodes specific metabolic pathways for survival in low oxygen environments.
- Other names
- Anaerobic Bacterial ChromosomeAnaerobic Bacterial PlasmideDNA (Anaerobic Bacteria)
02
Mechanism of action
Antibiotics target bacterial DNA replication, transcription, or translation; some target DNA gyrase/topoisomerase; others interfere with DNA structure or synthesis. Some experimental drugs target eDNA to disrupt biofilms.
03
Biological functions
Genetic information storageReplicationTranscriptionTranslationHorizontal gene transferBiofilm formationAdhesionMetabolism (anaerobic)Adaptation to anaerobic environments
04
Disease associations
Infection (Anaerobic Bacterial Infections)Biofilm-associated infectionsAntibiotic resistancePathogenicity
05
Safety considerations
Development of antibiotic resistanceDisruption of normal microbiotaOff-target effects of DNA-targeting drugs
06
Interacting drugs
Antibiotics (e.g., Metronidazole, Clindamycin, Beta-lactams)
3 more in the full profile.
07
Biomarkers
Presence/absence of specific resistance genes (e.g., via PCR)eDNA concentration in infection sitesIdentification of specific anaerobic bacterial species (e.g., via 16S rRNA sequencing)
Beyond the preview
Go deeper on Bacterial DNA (Anaerobic Bacteria) (N/A).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bacterial DNA (Anaerobic Bacteria) (N/A).